Late-stage Parkinson's disease (LSPD) represents an under-recognized and under-studied phase of PD characterized by severe axial motor symptoms, high non-motor burden, cognitive impairment, functional dependence, and substantial caregiver involvement. Despite its major clinical and socioeconomic impact, LSPD seem to be...
Margherita Fabbri, Silvia Gallo, Tiago Machado et al.· Journal of Parkinson's Disea...· 0 citations
BACKGROUND
Levodopa is the gold-standard therapy for motor symptoms in Parkinson's disease (PD). However, individual responses vary substantially among patients, and the biological mechanisms underlying this heterogeneity remain incompletely understood.
OBJECTIVE
This study aimed to investigate the neural substrates...
N. Betrouni, Maia Ketelers, Romain Viard et al.· Neurobiology of Disease· 0 citations
BACKGROUND AND OBJECTIVES
Recent reports have suggested that levodopa exposure may contribute to freezing of gait (FOG), but this relationship remains controversial because of confounding by disease severity and duration. Our goal was to assess the relationship between levodopa use and FOG incidence and severity.
MET...
Raquel Barbosa, P. Bastos, O. Rascol et al.· Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.